Cite
THE ASSOCIATION BETWEEN CONCOMITANT PROTON-PUMP INHIBITOR USE AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH PRASUGREL VERSUS CLOPIDOGREL AND MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS STUDY
MLA
Nicolau, Jose C., et al. “The Association between Concomitant Proton-Pump Inhibitor Use and Clinical Outcomes in Patients with Acute Coronary Syndromes Treated with Prasugrel Versus Clopidogrel and Managed without Revascularization: Insights from the Trilogy Acs Study.” Journal of the American College of Cardiology (JACC), vol. 61, Mar. 2013, p. E39. EBSCOhost, https://doi.org/10.1016/S0735-1097(13)60040-6.
APA
Nicolau, J. C., Bhatt, D., Roe, M., Neely, B., Corbalan, R., Leiva-Pons, J., Martinez, F., Goodman, S., Brown, E., Verheugt, F., Armstrong, P., White, H., Fox, K., Prabhakaran, D., & Ohman, E. M. (2013). The Association between Concomitant Proton-Pump Inhibitor Use and Clinical Outcomes in Patients with Acute Coronary Syndromes Treated with Prasugrel Versus Clopidogrel and Managed without Revascularization: Insights from the Trilogy Acs Study. Journal of the American College of Cardiology (JACC), 61, E39. https://doi.org/10.1016/S0735-1097(13)60040-6
Chicago
Nicolau, Jose C., Deepak Bhatt, Matthew Roe, Benjamin Neely, Ramon Corbalan, Jose Leiva-Pons, Felipe Martinez, et al. 2013. “The Association between Concomitant Proton-Pump Inhibitor Use and Clinical Outcomes in Patients with Acute Coronary Syndromes Treated with Prasugrel Versus Clopidogrel and Managed without Revascularization: Insights from the Trilogy Acs Study.” Journal of the American College of Cardiology (JACC) 61 (March): E39. doi:10.1016/S0735-1097(13)60040-6.